· web viewte & time program nov. 12nd day 0 nov. 13rd day 1 nov. 14th day 2 nov. 15th day 3...
TRANSCRIPT
te & Time Program Nov. 12ndDay 0
Nov. 13rdDay 1
Nov. 14thDay 2
Nov. 15thDay 3
Nov. 16thDay 4
08:30-12:00
Track 1: Outlook for Global Market Trend of Drug Delivery Systems
RegistrationAll Day
Opening Ceremony&Nobel Laureates Forum
Mini-Plenary Lectures
13:30-17:30 Track 1
08:30-12:00
Track 2:Breaking Research and Innovative DDS Technologies
RegistrationAll Day
Opening Ceremony&Nobel Laureates Forum
Mini-Plenary Lectures
Session 2-1 Session 2-2
Session 2-5Session 2-6Session 2-7
13:30-17:30 Entrepreneurs Forum
Chinese ForumSection 1
Session 2-3Session 2-4
Session 2-8Session 2-9Session 2-10
08:30-12:00 Track 3:Innovative DDS Technology Targeting Different Route of Administration
RegistrationAll Day
Opening Ceremony&Nobel Laureates Forum
Mini-Plenary Lectures
Session 3-1 Session 3-2
Session 3-5Session 3-6
13:30-17:30 Entrepreneurs Forum
Chinese ForumSection 2
Session 3-3Session 3-4
Session 3-7Session 3-8
08:30-12:00 Track 4:Novel Technologies for Biotherapeutic Drug Delivery
RegistrationAll Day
Opening Ceremony&Nobel Laureates Forum
Mini-Plenary Lectures
Session 4-1
Session 4-4
13:30-17:30 Entrepreneurs Forum
Chinese ForumSection 3
Session 4-2Session 4-3
Session 4-5
08:30-12:00 Track 5: Applications of New DDS for Treating Major Diseases
RegistrationAll Day
Opening Ceremony&Nobel Laureates Forum
Mini-Plenary Lectures
Session 5-2
13:30-17:30 Entrepreneurs Forum
Panel Discussion I
Session 5-1
Session 5-3
08:30-12:00 Track 6:Nanotechnologies for Drug Delivery Systems
RegistrationAll Day
Opening Ceremony&Nobel Laureates Forum
Mini-Plenary Lectures
Session 6-3Session 6-4
13:30-17:30 Entrepreneurs Forum
Panel Discussion II
Session 6-1Session 6-2
Session 6-5
08:30-12:00 Track 7:Medical Devices for Drug Delivery, Surgery and Therapy
RegistrationAll Day
Opening Ceremony&Nobel Laureates Forum
Mini-Plenary Lectures
Session 7-1Session 7-2
Session 7-5Session 7-6
13:30-17:30 Entrepreneurs Forum
Panel Discussion III
Session 7-3Session 7-4
Session 7-7Session 7-8
08:30-12:00 Young Scientist Forum
RegistrationAll Day
Opening Ceremony&Nobel Laureates Forum
Mini-Plenary Lectures
13:30-17:30 YSF 1YSF 2
18:30-20:30 Social Events
Welcome Dinner and Art Performance
Social Dinner
Social Dinner
Social Dinner
BIT's 3rd Annual Symposium of Drug Delivery Systems 2013
Theme: New Horizons on Drug Delivery Routes and Technologies
主题:给药途径和技术的新视野Time: November 13-16, 2013 Venue: Hainan International Convention & Exhibition Center, China
Program Layout
Track 1: Outlook for Global Market Trend of Drug Delivery Systems
Track 2: Breaking Research and Innovative DDS Technologies
Track 3: Innovative DDS Technology Targeting Different Route of Administration
Track 4: Novel Technologies for Biotherapeutic Drug Delivery
Track 5: Applications of New DDS for Treating Major Diseases
Track 6: Nanotechnologies for Drug Delivery Systems
Track 7: Medical Devices for Drug Delivery, Surgery and Therapy
Track 8: Young Scientist Research
Social Events • Pre-conference Activities • University Alliance Activities • High School Students • Blog Discussion and Chat on Drug Delivery Systems • Welcome Banquet • Networking Cocktail Party • Chinese Art Performance
• Movie of Drug Delivery Systems • Career Bazaar • Matchmaking • Educational Training Courses • Interact with Communities (Industries, Colleges, and Research Institutes) • Industrial Showcase • Tech-Tour
Product and Technology Exposition
Preliminary Program
Mini-Plenary Lectures
Mini-Plenary Lectures Time: 08:30-12:00, Nov. 14th, 2013 (Thursday)
Moderator Dr. Diane J. Burgess, Distinguished Professor, University of Connecticut, USA
08:30-08:35 Moderator's Introduction
08:35-09:05
Title: Lipoamino Acids and Sugars in Drug/Peptide/Vaccine DeliveryDr. Istvan Toth, Professor, University of Queensland, Australia
09:05-09:10 Questions Time
09:10-09:40
Title: Polymer Therapeutics: Nanoscale Amphiphilic Macromolecules that Inhibit Oxidized Low-Density Lipoprotein Uptake Dr. Kathryn E. Uhrich, Founder, Polymerix Corporation, Professor and Dean, Rutgers University, USA
09:40-09:45 Questions Time
09:45-10:15
Title: Molecular Targets for Liver Cancer and Treatment with TCMDr. Hsiang-Fu Kung, Professor, Stanley Ho Centre for Emerging Infectious Diseases, the Chinese University of Hong Kong, Hong Kong, China
10:15-10:20 Questions Time
10:20-10:50
Title: Implantable, miniaturized biosensors for glucose and metabolic monitoring Dr. Diane J. Burgess, Distinguished Professor, University of Connecticut, USA
10:50-10:55 Questions Time
10:55-11:25 Dr. Henry Sun, President and CEO, Tasly Pharmaceuticals, Inc.; Vice President, and CEO, Tasly Group Co. Ltd.; Professor, Tianjin University, China
11:25-11:30 Questions Time
Track 1: Outlook for Global Market Trend of Drug Delivery Systems
Track 1: Global Policy, Market Trend, Business Development and of DDS Time: 13:30-17:10, Nov. 14th, 2013 (Thursday)
Chair:
Dr. Danchen Gao, Director of Intellectual Property Strategy, Abbott Laboratories, USA
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Modifying the Wheel to Fit Patient BetterDr. Danchen Gao, Director of Intellectual Property Strategy, Abbott Laboratories, USA
14:00-14:25 Title:Drug delivery devices: challenges to develop the right solution for patients and improve adherenceDr. Patrice Lewko, VP Marketing & Innovation, Rexam Healthcare, France
14:25-14:50 Title: Novel Drug Delivery System Outlook for next 5-10 years in China and Globally Mr. Zhirui Zhai, Chairman, Aventis Pharma Group, China
14:50-15:15 Title: Experience with pharmaceutical evaluation of drug delivery systems within EUDr. Ivana Tasevska, Pharmaceutical Assessor, State Institute for Drug Control, Czech Republic
15:15-15:30 Coffee Break
Track 2: Breaking Research and Innovative DDS Technologies
Session 2-1: Frontier of New Technology for Drug Delivery SystemsTime: 08:30-12:10, Nov. 15th, 2013 (Friday)
Chair: Dr. Ciriaco Maraschiello, Director, Drug Discovery & Translational Medicines, CRS Strategic Portfolio Manager, Harlan Laboratories Ltd., Switzerland
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Toxicity of Vehicles used in Preclinical Drug DevelopmentDr. Ciriaco Maraschiello, Director, Drug Discovery & Translational Medicines, CRS Strategic Portfolio Manager, Harlan Laboratories Ltd., Switzerland
09:00-09:25 Title: Design of oral solid metered drug delivery systems using engineered particlesDr. Subodh Deshmukh, SVP R&D Ranbaxy Laboratories Limited, India
09:25-09:50 Title: TBDDr. Pompilia Ispas Szabo, Director Pharmaceutical Development, Acasti Pharma, Canada
09:50-10:15 Title: Supercritical Fluid Particle Design for Novel Drug Delivery SystemDr. Yongda Sun, Professor, Tianjin Pharmaceutical Research Institute, KingYork Group,China
Session 2-2: Improved Liposome Technologies Time: 08:30-12:10, Nov. 15th, 2013 (Friday)
Chair: Dr. Gigi Ngar Chee Chiu, Assistant Professor, National University of Singapore, Singapore
08:30-08:35 Chair's Introduction
08:35-09:00 Speech Opportunity Available
09:00-09:25 Title: Functionalised liposomes for construction of recombinant vaccine Dr. Jaroslav Turanek, Head, Veterinary Research Institute, Czech Republic
09:25-09:50 Title: Fixed-dose liposomal drug combination products for cancer: An evaluation of drug loading methods Dr. Gigi Ngar Chee Chiu, Assistant Professor, National University of Singapore, Singapore
09:50-10:15 Title:Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrateDr. Xing-guo Mei, Professor, Academy of Military Medical Sciences, China
10:15-10:30 Coffee Break
Session 2-3: Drug Delivery Development of Poorly Soluble Drugs ( I )Time: 13:30-17:10, Nov. 15th, 2013 (Friday)
Chair:
Dr. Soren Lund Kristensen, CEO, Particle Analytical ApS, Denmark
Co-Chair: Dr.Yanfeng Zhang, Chief Scientific Officer, Crystal Pharmatech Inc., China
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Importance of Accurate Particle Size Determination for Small Particles: How to Calculate the "Right" Sizes from Laser Diffraction ResultsDr. Soren Lund Kristensen, CEO, Particle Analytical ApS, Denmark
14:00-14:25 Title: Amorphous Solid Dispersion in Drug Delivery of Poorly Soluble Drugs Dr.Yanfeng Zhang, Chief Scientific Officer, Crystal Pharmatech Inc., China
14:25-14:50 Title:Strategy to Enhance Bioavailability of Poorly Soluble DrugsDr. Mingqiu Lu, Formulation Group Leader, pCMC, pRED, Roche R&D, China
14:50-15:15 Title: Nanotechnology for the Solubilization of Poorly Soluble DrugsDr. Sebastian Koltzenburg, Principal Scientist, BASF Corporation, Germany
15:15-15:30 Coffee Break
15:30-15:55 Title: Drug Delivery of Poorly Water-Soluble Drugs by Amorphous ApproachesDr. Jingjun (Jim) Huang, Founder and CEO, Ascendia Pharmaceuticals LLC, USA
15:55-16:20 Title: Insoluble Drug Fast Release to Improve the DissolutionDr. Zhou Peng, Business Development Manager, DFE Pharma Company, China
16:20-16:45 Title: Mesoporous nanoparticles for improving solubility of poorly soluble drugs Dr. S. J. Rajput, Professor, The Maharaja Sayajirao University of Baroda, India
16:45-17:10 Panel Discussion
Session 2-4: Sustained, Delayed-Release, Controlled or Modified-release Drug Delivery Time: 13:30-17:10, Nov. 15th, 2013 (Friday)
Chair: Dr. Guojie Wang, Professor, University of Science and Technology Beijing, China
Co-Chair: Dr. Shao Xiang Lu, President, Broda Technologies Co., Ltd., China
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Study on High Drug Loading Osmotic Pump Delivery SystemDr. Charlie Wang, R&D, Dow Chemical(China)Company Limited, China
14:00-14:25 Title: Towards a mechanistic understanding of controlled drug release from polymer coated pelletsDr. Christian von Corswant, Principal Scientist OCR Formulation Science, AstraZeneca R&D, Sweden
14:25-14:50 Title: Controlled delivery of poorly water soluble drugsDr. Jingjun (Jim) Huang, Founder and CEO, Ascendia Pharmaceuticals LLC, USA
14:50-15:15 Title: Critical parameters for robust modified release oral drug deliveryDr. Catherine Zhu, Technical Services Manager, Colorcon, Inc., China
15:15-15:30 Coffee Break
15:30-15:55 Title: IntelliGelTM A Supramolecular Smart Hydrogel Drug Delivery SystemDr. Shao Xiang Lu, President, Broda Technologies Co., Ltd., China
15:55-16:20 Title: Drug Delivery Systems for Cancer Treatment: Past, Present and FutureDr. Rachit Ohri, Program Manager, Covidien Ltd, USA
16:20-16:45 Title:Synthetic and Modified Natural Polymer Hydrogels as Carriers in Drug Delivery Dr. K. Subramanian, Department of Biotechnology Bannari Amman Institute of Technology, India
16:45-17:10 Panel Discussion
Session 2-5: Targeted Delivery Technologies-Site-Specific Drug Delivery Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. Yueqing Gu, Professor and Director, China Pharmaceutical University, China
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Transport of Liposome Entrapped Substances into Oral Mucosa as Measured by EPROxymetry Dr. Petelin Milan, Professor, Univerza v Ljubljani, Slovenia
09:00-09:25 Title: Electromagnetic Focusing and Navigation for Intranasal Target Drug Delivery Dr. Jinxiang Xi, Assistant Professor, Mechanical and Biomedical Engineering, Central Michigan University, USA
09:25-09:50 Speech Opportunity Available
09:50-10:15 Title: 2DG-based Adriamycin Complex for Targeted Cancer
TherapyDr. Yueqing Gu, Professor and Director, China Pharmaceutical University, China
10:15-10:30 Coffee Break
Session 2-6: New Biocompatible Polymers, Biopolymers, Coatings and Bioabsorbable Intelligent Materials Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair:
Dr. Kathryn E. Uhrich, Founder, Polymerix Corporation, Professor and Dean, Rutgers University, USA
Co-Chair: Dr. Qiqing Zhang, Professor, Xiamen University, China
08:30-08:35 Chair's Introduction
08:35-09:00 Title:Biodegradable Semi-solids and Epoxy Elastomers for Drug Delivery and Surface CoatingDr. Chun Wang, Associate Professor, University of Minnesota, USA
09:00-09:25 Title:Cyclodextrin-based pH-sensitive star polymer for drug deliveryDr. Qiqing Zhang, Professor, Xiamen University, China
09:25-09:50 Title: Polymeric Materials for Controlled ReleaseDr. Guojie Wang, Professor, University of Science and Technology Beijing, China
09:50-10:15 Title: Nanocarriers Based on Lipid for Small Interfering RNA Delivery Dr. Xin Zhang, Professor, Institute of Process Engineering, Chinese Academy of Sciences, China
10:15-10:30 Coffee Break
10:30-10:55
Title:Synthesis, Characterization and pH-Responsive Self-Assembly Behavior of Amphiphilic Multiarm Star Triblock Copolymers Based on PCL, PDEAEMA and PEGDr. Li Juan Zhang, Professor, South China University of Technology, China
10:55-11:20 Title: Cyclized Amphiphilic Block Copolymers toward Controlled Release
Dr. Takuya Yamamoto, Assistant Professor, Tokyo Institute of Technology, Japan
11:20-11:45 Speech Opportunity Available
11:45-12:10 Panel Discussion
Session 2-7: Implantable Drug Delivery Systems Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. Bin Huang, Intersect ENT Inc, USA
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Factors Facilitating Optimised Intraparenchymal Drug Delivery – A Method That WorksDr. Max Woolley, Technical Lead, Renishaw plc, UK
09:00-09:25 Title:Effective Clinical Trial Strategies for Combination ProductsMr. An Liu, General Manager, NAMSA China, China
09:25-09:50 Title: The PROPEL Mometasone Furoate Implant, Improving Outcomes of Sinus SurgeryDr. Bin Huang, Intersect ENT Inc, USA
09:50-10:15 Speech Opportunity Available
10:15-10:30 Coffee Break
Session 2-8: Prodrugs for Better Efficacy Time: 13:30-17:10, Nov. 16th, 2013 (Saturday)
Chair: Mr.Ole Møller Dall, Formulation Manager, Biopharma Technical Service,Novozymes Biopharma DK,Denmark
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Recombinant Ingredients and Related Technologies - Breakthrough Solution for Drug Stabilization, Drug Delivery and half Life ExtensionMr.Ole Møller Dall, Formulation Manager, Biopharma Technical Service,Novozymes Biopharma DK,Denmark
14:00-14:25 Title: Design and synthesis of adefovir mixed phosphonate prodrugs with reduced renal cell toxicity by using human renal Organic Anion Transporter 1 (hOAT1) as potential targetsDr. Xiao Zhong Fu, Professor, Guiyang Medical College, China
14:25-14:50 Speech Opportunity Available
14:50-15:15 Speech Opportunity Available
15:15-15:30 Coffee Break
Session 2-9: Drug Delivery Development of Poorly Soluble Drugs ( II )Time: 13:30-17:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. Yongda Sun, Professor, Tianjin Pharmaceutical Research Institute, KingYork Group, China
13:30-13:35 Chair' s Introduction
13:35-14:00 Title: Supercritical Fluid Particle Design for Poorly Water-Soluble Drug Dr. Yongda Sun, Professor, Tianjin Pharmaceutical Research Institute, KingYork Group, China
14:00-14:25 Title: Solid state chemistry and mechanochemistry for drug delivery Dr. Elena V. Boldyreva, Professor, Head, Novosibirsk State University, Russia
14:25-14:50 Title: Pharmaceutical Cocrystral for improving poorly Soluble drugDr. Yan Xie, Associate Professor, Shanghai University of Traditional Chinese Medicine, China
14:50-15:15 Title:Control of Co-crystal and Polymorphs of Pharmaceuticals by Solution Crystallization Dr. Kwang-Joo Kim, Professor, Hanbat National University, South Korea
15:15-15:30 Coffee Break
Session 2-10: Encapsulation Technologies Time: 13:30-17:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. Yves Duccini, Global R&D Director, SEPPIC, Inc., France
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Two Novel Technologies for Encapsulation of Actives in Pharmaceutical, Food and Cosmetics ApplicationsDr. Yves Duccini,Global R&D Director, SEPPIC, Inc., France
14:00-14:25 Speech opportunity available
14:25-14:50 Title: Role of Microencapsulation Technology in Product DevelopmentDr. Bhaumik Patel, Principal Scientist (Encapsulation, Product Development), Vision Processing Technologies, USA
14:50-15:15 Title:Temperature-responsive polymers as nanocarriers for gene deliveryDr. Anna-Lena Kjoniksen, Researcher, University of Olso, Norway
15:15-15:30 Coffee Break
Track 3: Innovative DDS Technology Targeting Different Route of Administration
Session 3-1: New Pulmonary Drug Delivery (Combined with session 7-3)Time: 08:30-12:10, Nov. 15th, 2013 (Friday)
Session 3-2: New Advances of Pediatric Drug Delivery (Combined with session 2-1)Time: 08:30-12:10, Nov. 15th, 2013 (Friday)
Session 3-3: New Oral, Transmucoadhesive and Buccal Drug DeliveryTime: 13:30-17:10, Nov. 15th, 2013 (Friday)
Chair: Dr. Nebiyou Getahoun, President, Pharma-Med Inc., USA
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Oral Protein-based Drug Delivery Prospects: ORMD-0801, an Insulin-based Case Study of Technological Feasibility Dr. Miriam Kidron, Chief Medical and Technology Officer, Oramed Pharmaceuticals Inc., Israel
14:00-14:25 Title: New Oral Transmucoadhesive and Buccal drug deliveryDr. Nebiyou Getahoun, President, Pharma-Med Inc., USA
14:25-14:50 Title: Nystatin Topical Nanosuspension with Improved Antifungal Efficacy
Dr. Gregoire Leclair, Director, Platform of Biopharmacy, Professor, University of Montreal, Canada
14:50-15:15 Title:Drug Delivery from Chewing Gum Dr. Bruno Provstgaard Nielsen, Scientist, Strategic Development IPR, Fertin Pharma A/S, Denmark
15:15-15:30 Coffee Break
15:30-15:55 Title: Recent Oral Mucosal Drug Delivery Technologies Dr. Michael J Rathbone, Professor and Dean, International Medical University, Malaysia
15:55-16:20 Title: Synthesis and in Vitro Evaluation of a Novel Polymeric Excipient for Buccal Drug Delivery SystemsFlavia Laffleur, Pharmacist, Research Scientist , University of Innsbruck, Austria
16:20-16:45 Title: Nanoparticle Strategies for Oral Insulin: Fact or Fiction?Dr. Zhi Min Wu, Lecturer, Xiangtan University, China
16:45-17:10 Panel Discussion
Session 3-5: New Advances of Pediatric Drug Delivery (Combined with session 7-3)Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Session 3-6: New Transdermal Patch and Topical Drug Delivery Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair:
Dr. Barry Gujral, Associate Director of Quality Engineering, Noven Pharmaceuticals, Inc, USA
Co-Chair: Dr. Faz Chowdhury, Chief Executive Officer, Nemaura Pharma, UK
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Development of Transdermal Patches Using Quality by Design and Computer SimulationsDr. Barry Gujral, Director of Quality Engineering, Noven Pharmaceuticals, Inc, USA
09:00-09:25 Title:Alaptide as Transdermal Penetration Modifier
Dr. Jiri Dohnal, Director, Research Institute for Pharmacy and Biochemistry (VUFB, s.r.o.), Czech Republic
09:25-09:50 Title:Transdermal delivery of biologics Dr. Faz Chowdhury, Chief Executive Officer, Nemaura Pharma, UK
09:50-10:15 Title: Extemporaneous Compounding, Dispensing and Administration of Transdermal PreparationsDr. Alfred T. Reiman, Professor/Pharmacist, State University of New York at Buffalo, USA
10:15-10:40 Title: Low-Cost Local Antibiotic Delivery Device: A Versatile Treatment Option for Deep Bone Infections and Soft Tissue SuppurationsDr. Dorottya Frank, Assistant Professor, University of Pécs, Hungary
Session 3-8: New Ocular Drug Delivery Time: 13:30-17:10, Nov. 16th, 2013 (Saturday)
Chair: Call for Chair
13:30-13:35 Chair's Introduction
13:35-14:00 Title:Microspheres in Ophthalmology: from lab bench to clinicDr. Martin Bakker, Senior Business Director, OctoPlus N.V., the Netherlands
14:00-14:25 Speech Opportunity Available
14:25-14:50 Title: Intravitreal Zero-order Release Levofloxacin Implant in an Experimental Model of EndophthalmitisDr. Hong Zhang, Deputy Head & Professor, First Affiliated Hospital of Harbin Medical University, China
14:50-15:15 Title: Small molecular hydrogel for ocular drug deliveryDr. Hao Chen, Professor, Wenzhou Medical College, China
15:15-15:30 Coffee Break
Track 4: Novel Technologies for Biotherapeutic Drug Delivery
Session 4-1: New Carriers for Biotherapeuticals Time: 08:30-12:10, Nov. 15th, 2013 (Friday)
Chair: Dr. Sabine Scheidler, Global Head Nucleic Acid Therapeutics Platform, Sanofi-Aventis Deutschland GmbH, Germany
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Advances in targeting and retention of the human, autologous, pluripotent stem cells to the regenerated zones of infarcted myocardium Dr. Marek Malecki, Professor, University of Wisconsin and President of the Phoenix Biomolecular Engineering Foundation, USA
09:00-09:25 Speech Opportunity Available
09:25-09:50 Speech Opportunity Available
09:50-10:15 Title: Novel Cell-Penetrating Peptides as Delivery Systems Dr. Yu-Hui Zhang, Associate Professor, Huazhong University of Science and Technology, China
Session 4-3: Innovative DDS for Vaccines Time: 13:30-17:10, Nov. 15th, 2013 (Friday)
Chair:
Dr. Sue Xiang, Senior Research Manager, Monash University, Australia
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Plant-made vaccines for developing countriesDr. Kathleen Laura Hefferon, Director, Professor, Cornell University, USA
14:00-14:25 Speech opportunity available
14:25-14:50 Title:TBDDr. Sue Xiang, Senior Research Manager, Monash University, Australia
14:50-15:15 Title: Carbohydrate Based Building Blocks for the Construction of Synthetic Self-Adjuvanting VaccinesBearing Multiple Peptide EpitopesDr. Vincent Fagan, University of Queensland, Australia
15:15-15:30 Coffee Break
Session 4-4: Advanced Polymeric Carriers for Peptide/Proteins Drugs Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. Paolo Ferruti, Professor, Universita di Milano, Italy
08:30-08:35 Chair's Introduction
08:35-09:00 Title:Modified Recombinant Human Albumins for Peptide and Protein Half-life ExtensionDr Mark Perkins,Customer Solutions Manager, Novozymes Biopharma, UK
09:00-09:25 Title: Poly(amidoamine) as peptidomimetic bioactive polymers and intracellular carriers for nucleic acids and proteinsDr. Paolo Ferruti, Professor, Universita di Milano, Italy
09:25-09:50 Speech opportunity available
09:50-10:15 Title:A New Peptide SeparationPrincipleOriginating from Unexpected Modes ofBindingbetweenBiomarker Peptides, Blood Proteins, and SorbentMaterialsDr. Hiroryuki Kabata, Chief Researcher, Japan Science and Technology Agency, Japan
10:15-10:30 Coffee Break
Session 4-5: Nucleic Acids (RNAi, DNA) for Gene Therapeutics Time: 13:30-17:10, Nov. 16th, 2013 (Saturday)
Chair:
Dr. Victor Knopov,Vice President, Pharmaceutical Development, Regulus Therapeutics Inc., USA
Co-Chair: Dr. Alan Y. Lu, Exe. Vice President, Sirnaomics, INC., USA
13:30-13:35 Chair's Introduction
13:35-14:00 Title:New paradigm in microRNA Delivery SystemsDr. Victor Knopov,Vice President, Pharmaceutical Development, Regulus Therapeutics Inc., USA
14:00-14:25 Title: Polypeptide Enhanced Delivery for siRNA TherapeuticsDr. Alan Y. Lu, Exe. Vice President, Sirnaomics, INC., USA
14:25-14:50 Title: Stimuli-Responsive Block Copolymer-based Polyplex Micelles for Long Blood Circulation and High Transfection Efficiency Dr. Zhishen Ge, Associate Professor, University of Science and Technology of China, China
14:50-15:15 Title: Leukostimulatory and anticancer effect of human double-stranded DNA preparation “Panagen” in experiments and in Phase II clinical trials for breast cancer treatmentDr. Sergey S Bogachev, Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences, Russia
15:15-15:30 Coffee Break
Track 5: Applications of New DDS for Treating Major Diseases
Session 5-1: Targeting Anticancer Drug Delivery Time: 13:30-17:10, Nov. 15th, 2013 (Friday)
Chair: Dr. Amotz Shemi, Chief Executive Officer, Silenseed LTD, Israel
Co-Chair: Dr. Huabing Chen, Professor, Soochow University, China
13:30-13:35 Chair's Introduction
13:35-14:00 Title:A novel RNAi-based platform for treatment of solid tumors: clinical results from treatment of pancreatic cancerDr. Amotz Shemi, Chief Executive Officer, Silenseed LTD, Israel
14:00-14:25 Title:Theranostic micelles for cancer imaging with high contrast and superior multimodal therapyDr. Huabing Chen, Professor, Head of the Nanomedicine Research Laboratory, College of Pharmaceutical Science, Soochow University, China
14:25-14:50 Title:Decreased Drug Distribution may be the Decisive Factor for Enhanced Chemoresistance in Pancreatic CancerDr. Yulian Wu, Directotr, Professor, Zhejiang University School of Medicine, China
14:50-15:15 Title: Antiangiogenic RNAi therapy for cancer treatmentDr. Naoto Oku, Professor, University of Shizuoka, Japan
Session 5-2: Challenges and Future Directions for CNS Drug Delivery Technology Development Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair: Call for Chair
08:30-08:35 Chairs Introduction
08:35-09:00 Title:Brain Delivery of Proteins via their Fatty Acid and Block Copolymer ModificationsDr. Xiang Yi, Research Assistant Professor, University of North Carolina at Chapel Hill, USA
09:00-09:25 Title: Targeted drug delivery into brain using MR-guided FUSDr. Juyoung Park, Research Fellow, Brigham and Women' s hospital and Harvard Medical School, USA
09:25-09:50 Title: targeted delivery of macromolecules into CNS mediated by peptide Dr. Ailing Fu, Professor, Southwest University, China
09:50-10:15 Title: Zonisamide Protects Spinal Motor Neuron from Glutame Mediated NeurotoxicityDr. Yasuo Iwasaki, Professor and Chairman, Department of Neurology, Toho University Omori Medical Center, Japan
Session 5-3: Current Innovative DDS for Treating Other Diseases Time: 13:30-17:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. Peter Laing, Director, Liposomal Glycobiology and Hepatology Product Development, United Therapeutics Europe Ltd., UK
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Engineering the Lipid Composition and Receptor-Tropism of Liposomes to Create Novel Inhibitors of HCV and Dengue Virus Infection and Vehicles for Antiviral DrugsDr. Peter Laing, Director, Liposomal Glycobiology and Hepatology Product Development, United Therapeutics Europe Ltd., UK
14:00-14:25 Speech Opportunity Available
14:25-14:50 Title: Therapeutic Approach towards Sustainable Effects in a Mouse Model of Angiogenesis Dr. Qinghua Sun, Professor, The Ohio State University, USA
14:50-15:15 Title: old and news about oct and stent Dr. Olivia Manfrini, Assistant Professor, University of Bologna, Italy
15:15-15:30 Coffee Break
Track 6: Nanotechnologies for Drug Delivery Systems
Session 6-1: Biopharmaceutical, Physiological and Clinical Considerations for Nanotechnology in Drug Delivery Time: 13:30-17:10, Nov. 15th, 2013 (Friday)
Chair: Dr. Daniel Scherman, Professor, Université René Descartes, France
Co-Chair: Dr. Jie Chen, Professor, University of Alberta, Canada
13:30-13:35 Chair's Introduction
13:35-14:00 Title:The Design and Development of a Novel Intravenous NanosuspenionDr. Nicholas Barker, VP, Pharmaceutical Sciences, Cubist Pharmaceuticals, USA
14:00-14:25 Title:Liposomal Based Nanoparticle For Drug DeliveryDr. Indu Javeri, President & CEO, CuriRx Inc, USA
14:25-14:50 Title: Mass Production of Nano-Hydrid Matrix Particles for Water Insoluble Drug with HGCP PlatformDr Zhigang Shen, Technical Director,NanoMaterials Technology Pte Ltd, Singapore
14:50-15:15 Title: Development of a Novel Cell Transfection System using Magnetic Nanoparticles Dr. Jie Chen, Professor, University of Alberta, Canada
15:15-15:30 Coffee Break
15:30-15:55 Title: Nanostructures for efficient in vivo RNA interference with multiple potential medical applications and for optical bioimagingDr. Daniel Scherman, Professor, Université René Descartes, France
15:55-16:20 Title:TBDDr. Jian-Hua Wang, University of Sydney, Australia
16:20-16:45 Title: The importance of magnetic interaction for drug delivery using nanoparticles (Ag, Au o Fe3O4)obtained by biological methodsNanokey®Dr.Jaime Santoyo Salazar, Research Associate Lotto Bio Nano Laboratories Sa De Cv Leon Guanajuato Mexico
16:45-17:10 Panel Discussion
Session 6-2: Targeted and Site-Directed Controlled Drug Delivery Using Nanotechnologies Time: 13:30-17:10, Nov. 15th, 2013 (Friday)
Chair:
Dr. Anas Chalah , Lecturer on Engineering Sciences, Director of Teaching labs,Director of Safety Program, Harvard University,USA
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Engineering of nano structures for targeted drug deliveryDr. Anas Chalah, Lecturer on Engineering Sciences ,Director of Teaching labs,Director of Safety Program,Harvard University,USA
14:00-14:25 Title: The Delivery of Thrombi-specific Nanoparticles Incorporating Oligonucleotides into Injured Cerebrovascular EndotheliumDr. Yu Hu, Professor, Huazhong University of Science & Technology, China
14:25-14:50 Title: Magnetic Capsules with Porous Nanoshell for Magnetically-Guided Drug Delivery SystemDr. Yoshitaka Kitamoto, Associate Professor, Tokyo Institute of Technology, Japan
14:50-15:15 Title:Application of Nanotechnology in Drug deliveryDr. Kusum V Devi, Professor and Head, Al-Ameen College of Pharmacy, India
15:15-15:30 Coffee Break
Session 6-3: Biocompatible and Biodegradable Materials, Dendrimers for Drug Nanoparticles Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. Vuong Trieu, CEO, IgDraSol Inc, USA
Co-Chair: Dr. Manfred Georg Krukemeyer, Professor, Radiation Hospital, Paracelsus Hospitals, Germany
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Paclitaxel nanomedicines- practical experiences in translational development and commercializationDr. Vuong Trieu, CEO, IgDraSol Inc, USA
09:00-09:25 Title: Nanotechnology in Liver CancerDr. Manfred Georg Krukemeyer, Professor, Radiation Hospital, Paracelsus Hospitals, Germany
09:25-09:50 Title:Cyclodextrins-based nanoplatforms for drug delivery Dr. Jianxiang Zhang, Professor, The Third Military Medical University, China
09:50-10:15 Title: Suppression of Liver Cancer Progression by Biocompatible Polymer-mediated Delivery of Programmed Cell Death Protein 4Dr. Hulin Jiang, Professor, China Pharmaceutical University, China
10:15-10:30 Coffee Break
10:30-10:55 Title: Polysaccharide-based Nanoparticles as a Drug Delivery System – Preparation and Physico-chemical CharacterizationDr. Helene Jonassen, Lecturer, University of Olso, Norway
10:55-11:20 Title: Cellular uptake and cytotoxicity studies of water soluble amine terminated silicon quantum dots using confocal laser scanning microscopy Dr. Yimin Chao, Senior Lecturer, University of East Anglia, UK
11:20-11:45 Title: Synthesis and micellization of a pH-Sensitive diblock copolymer for Drug DeliveryDr. Stella Georgiado, Lecturer, Loughborough University, UK
11:45-12:10 Speech opportunity available
Session 6-4: Nano-Architectures/Structures: Nanotubes, Nanorods, Nanofiber Scaffolds and Fullerenes for Nanomedicine Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. Jun-Jie Zhu, Professor, Nanjing University, China
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Miniature Sources for Radiation Therapy Produced from Nano-and Single-Crystal MaterialsDr. Taubin Mikhail ,Professor, FSUI Luch", Russia
09:00-09:25 Title: Highly dispersible PEGylated Graphene/Au composites as gene delivery vector and potential cancer therapeutic agent Dr. Jun-Jie Zhu, Professor, Nanjing University, China
09:25-09:50 Title: Retarded Drug Release from Calcium Phosphate Capped TiO2
Nannotube arraysDr. Jinsong Liu, Wenzhou Medical College, China
09:50-10:15 Speech Opportunity available
10:15-10:30 Coffee Break
Session 6-5: Nanotechnology for the Delivery of Small Molecules (Combined with session 6-1)Time: 13:30-17:10, Nov. 16th, 2013 (Saturday)
Track 7: Medical Devices for Drug Delivery, Surgery and Therapy
Session 7-1: Latest Breakthroughs in Drug Delivery Systems and Smart Drug Release Devices Time: 08:30-12:10, Nov. 15th, 2013 (Friday)
Chair:
Dr. Dirk Jansen, Professor, Hochschule Offenburg Institute, Germany
Co-Chair: Dr. Morten Nielsen, CEO, Bang & Olufsen Medicom, Denmark
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Are Electronic Drug Delivering Devices like ePill© the Next Generation of Gastrointestinal Medical Treatment?Dr. Dirk Jansen, Professor, Hochschule Offenburg Institute, Germany
09:00-09:25 Title: A unique self-regenerating surface for medical devices to prevent clinical drug resistanceDr. Naseem Theilgaard, Head of new medical devices initiatives, Danish Technological Institute, Denmark
09:25-09:50 Title: The Strategic Opportunities of Thinking Intelligent Devices into the Drug Delivery Equation Dr. Morten Nielsen, CEO, Bang & Olufsen Medicom, Denmark
09:50-10:15 Title: Novel Autoinjectors Designs Addressing Various Patients Needs –
Disposable & Reusable, Low-High Viscosity, PFS and Vials Dr. David Daily, CEO, DALI Medical Devices, Director for R&D and Business Development, Injectable Drug Delivery Devices, Elcam Medical, Israel
10:15-10:30 Coffee Break
10:30-10:55 Title: New Method for The Treatment of Parkinson's Disease Using Microtablets and a Dosing Device Dr. Jack Spira, CEO, Sensidose AB, Sweden
10:55-11:20 Title: Optimising Drug Release from Coronary Stents: combined approaches using mathematical modelling and novel materials Dr. Christopher McCormick, Research Fellow, University of Strathclyde, UK
11:20-11:45 Title: Characterization of Bioabsorbable PLGA Coating on A Drug-eluting stentDr. Yen-Lane Chen, Senior Research Fellow, Boston Scientific Co, USA
11:45-12:10 Panel Discussion
Session 7-2: Needle-Free, Needle Array and Safety Syringe Drug Delivery Systems Time: 08:30-12:10, Nov. 15th, 2013 (Friday)
Session 7-3: Advancements in Orally Inhaled and Nasal Drug Delivery SystemTime: 13:30-17:10, Nov. 15th, 2013 (Friday)
Chair: Dr. Jason Suggett, Group Director, Science and Technology, Trudell Medical Int, Canada
Co-Chair:
Dr. Xian-Ming Zeng, Vice President, Respiratory RD, TEVA Branded Pharmaceutical, USA
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Challenges and Opportunities of Developing Inhaled Products for Emerging MarketsDr. Xian-Ming Zeng, Vice President, Respiratory RD, TEVA Branded Pharmaceutical, USA
14:00-14:25 Title: The Use of Medical Devices to Enhance and/or Complement Drug Delivery for Inhalation Therapy Dr. Jason Suggett, Group Director, Science and Technology, Trudell
Medical Int, Canada
14:25-14:50 Title:Current Perspectives on Inhaled Drug TherapyDr. Anthony Hickey, Founder, President and Chief Executive Officer, Cirrus Pharmaceuticals Inc, USA
14:50-15:15 Title: Inhalation of Larger Aerosols at Lower Flow Rates Compared to Smaller Airflows and Higher Inhalation Flow RateDr. Ola Nerbrink, Deputy Research Director, Swedish Defence Agency, Sweden
15:15-15:30 Coffee Break
15:30-15:55 Title: New Integrated Approach Towards Improving Inhaler Education Dr. Fiona Shetty, Program Director, Use Inhaler LLC, USA
15:55-16:20 Title: Preformulation and Biopharmaceutical Support in Formulation Development for Inhalation Dr. Andrei Blasko, Senior Fellow, Pharmaceutical and Analytical Development, Novartis, USA
16:20-16:45 Title: Lung Targeted Drug Delivery System by Way of Liposomes Prepared by New TechniquesDr. Ling Zhao, Associate Professor, Luzhou Medical College, China
16:45-17:10 Panel Discussion
Session 7-4: Drug Eluting Stent Technologies (Combined with session 7-1)Time: 13:30-17:10, Nov. 15th, 2013 (Friday)
Session 7-5: On-command, Self-regulated and Bioresponsive Triggered DDS On-command Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. H. Frederic Hildebrand, Research Director, University Lille Nord de France, France
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Orthopedic Implants and Bone Substitutes with Cyclodextrin Polymers as Carrier System for Local Drug DeliveryDr. H. Frederic Hildebrand, Research Director, University Lille Nord de France, France
09:00-09:25 Title: TBDDr. Rongsheng Zhang, Director and Co-Founder, NPZ Technology
Limited, UK
09:25-09:50 Speech Opportunity Available
09:50-10:15 Title: Mutifunctional Drug Eluting Stent based on poly-b-cyclodextrin and chitosan Layer-By-Layer-AssemblyDr. Feng Chai, University Lille Nord de France, France
10:15-10:30 Coffee Break
Session 7-6: Prefilled Syringes & Injectors Time: 08:30-12:10, Nov. 16th, 2013 (Saturday)
Chair: Dr. David Haase, Senior Manager Device Development, Genentech Inc., USA
Co-Chair: Dr. David Daily, CEO, DALI Medical Devices, Director for R&D and Business Development, Injectable Drug Delivery Devices, Elcam Medical, Israel
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Function versus Design, Market Trends for Self-Injection DevicesDr. Volker Wirth, VP Global Business Development, Haselmeier GmbH, Switzerland
09:00-09:25 Title: Development of Injection System and Future Expectation of Prefilled SyringesDr. Daikichiro Murakami, Director of PDA Japan Chapter and the chair of Medical Device Committee of PDA Japan; Technical Advisor, Green Technology Division, Taikisha Ltd. Japan
09:25-09:50 Title:Technology Improvements for Delivering Biologic DrugsDr. David Haase, Senior Manager Device Development, Genentech Inc., USA
09:50-10:15 Title: Cost Effective for Instantaneous Pre-filled SyringesMr. Zhuanghe Tian, Director and General Manager, Beijing Everon Economic Company Ltd.,China
10:15-10:30 Coffee Break
Session 7-7: Image-guided Drug Delivery Time: 13:30-17:10, Nov. 16th, 2013 (Saturday)
Session 7-8: Microelectronics, MEMS Sensors, Microfluidics, Micro-components for Medical DevicesTime: 13:30-17:10, Nov. 16th, 2013 (Saturday)
Chair:
Dr. Haifeng Frank Ji, Associate Professor, Drexel University, USA
Co-Chair: Call for Co-Chair
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Optimizing Performance of Microcantilever SensorsDr. Haifeng Frank Ji, Associate Professor, Drexel University, USA
14:00-14:25 Title: Production of microbubbles in a microfluidic device with a capillary gas jet for medical imaging applicationsDr. Chuanpin Chen, Associate Professor, Central South University, China
14:25-14:50 Title: Microfluidic Chips for Generation of Functional Micro/Nano-Capsules for Targeted Drug DeliveryDr. Jianhua Zhou, Associate Professor, Sun Yat-Sen University, China
14:50-15:15 Speech opportunity available
15:15-15:30 Coffee Break
Track 8: Young Scientist Research
Track 8: Young Scientist Research Time: 13:30-17:10, Nov. 13th, 2013 (Wednesday)
Chair: Dr. Mohammed Maniruzzaman, Postdoctoral Research Associate, University of Greenwich, UK
Co-Chair: Dr. Rishi Paliwal, Assistant Professor, Columbia Institute of Pharmacy, India
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Neuropeptide Y Controls Hepatic Triglycerides secretion via the Sympathetic Nerve in arcuate nucleus lesionsed ratsDr. Lei Pei, Postdoctoral Fellow, Tongji Medical College, Huazhong University of Science and Technology, China
14:00-14:25 Title: Lipid and Polymer Nanoparticles for siRNA Delivery from Bench to Bedside Dr. Yuanyu Huang, Postdoctoral Research Fellow, Peking University, China
14:25-14:50 Title: Fabrication of micro/nano-particles of drugs for pharmaceutical applicationsDr. Mitali Kakran, Scientist, Institute of Materials Research and Engineering (IMRE) A*STAR, Singapore
14:50-15:15 Speech Opportunity Available
15:15-15:30 Coffee Break
15:30-15:55 Title:Molecular Modelling and X-ray Photoelectron Spectroscopy for the Predictions of Drug-Polymer Intermolecular Interactions in Solid DispersionsDr. Mohammed Maniruzzaman, Postdoctoral Research Associate, University of Greenwich, UK
15:55-16:20 Title: Functional Nanocarrier(s) for Oral Delivery of Low Molecular Weight HeaprinDr. Rishi Paliwal, Assistant Professor, Columbia Institute of Pharmacy, India
16:20-16:45 Title: Implementing NIR Spectroscopy as a Process Analytical Technology (PAT) Tool in Hot-melt Extrusion (HME) Processing followed by Quality by Design (QbD) approach.Muhammad Tariqul Islam, PhD Research Student, School of Science, University of Greenwich, UK
16:45-17:10 Panel Discussion